Language selection

Search

2012-07-24 - Male

452481

Adverse reaction report number 452481
Latest AER version number 0
Market authorization holder AER number ALL1201203423
Initial received date 2012-07-24
Latest received date 2012-07-24
Age N/A
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report MAH
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral10 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug ineffective
Headache
Date modified: